Hypofractionated radiotherapy for prostate cancer: how far can we go?
Hypogefractioneerde radiotherapie voor prostaatkanker: hoe ver kunnen we gaan?
The general purpose of this thesis was to investigate the feasibility of moderate and extreme hypofractionated radiotherapy for prostate cancer, with emphasis on treatment induced side effects. In this context, in all clinical studies toxicity was scored by both physicians and patients, using patient self-assessment questionnaires (PSAQ).
|B.J.M. Heijmen (Ben) , L. Incrocci (Luca)|
|Erasmus University Rotterdam|
|Organisation||Department of Radiation Oncology|
Aluwini, S. (2016, November 16). Hypofractionated radiotherapy for prostate cancer: how far can we go?. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/94037
|stellingen-Aluwini.pdf Final Version , 142kb|